Know Cancer

or
forgot password
  • cancer clinical trials in normal, IL

  • Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Community Cancer Center

    Trial Locations
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Illinois CancerCare - Community Cancer Center
    Normal, Illinois 61761
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Mid-Illinois Hematology-Oncology Associates at Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Kidney Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Illinois CancerCare-Community Cancer Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Lymphoma
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Mid-Illinois Hem/Onc Asoc
    Normal, Illinois 61761
    Chronic Myeloid Leukemia
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center Foundation
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Illinois CancerCare-Community Cancer Center

    Trial Locations
    Illinois CancerCare-Community Cancer Center
    Mid-Illinois Hematology Oncology Associates
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Illinois CancerCare-Community Cancer Center
    Normal, Illinois 61761
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    S0820, Adenoma and Second Primary Prevention Trial
    Community Cancer Center Foundation
    Normal, Illinois 61761
    Colorectal Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Lymphoma
    Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
    Illinois CancerCare - Community Cancer Center
    Normal, Illinois 61761
    Cancer
    Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Lymphoma
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    BroMenn Regional Medical Center

    Trial Locations
    BroMenn Regional Medical Center
    Community Cancer Center
    Illinois CancerCare - Community Cancer Center
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Community Cancer Center Foundation

    Trial Locations
    Community Cancer Center Foundation
    Illinois CancerCare-Community Cancer Center
    Mid-Illinois Hematology Oncology Associates
    Breast Cancer